WDR45 and cancer: Given that mutations of WIPI4 result in reduced stability of the protein in patients with BPAN1, we first depleted WIPI4 using small interfering RNA (siRNA) targeting WD repeat domain 45 (WDR45) to mimic the disease condition in cultured cancer cell lines.